Skip to main content
PLOS One logoLink to PLOS One
. 2025 Sep 8;20(9):e0322685. doi: 10.1371/journal.pone.0322685

Normative serum cortisol levels in second and third trimesters and their associated factors: A prospective cohort study from Sri Lanka

Ishani Menike 1,#, Shashanka Rajapakse 2,3,#, Gayani Amarasinghe 4, Janith Warnasekara 4, Nuwan Darshana Wickramasinghe 4, Thilini Agampodi 4,5, Suneth Buddhika Agampodi 4,5,6,*
Editor: Surangi Jayakody7
PMCID: PMC12416640  PMID: 40920792

Abstract

Objective

To describe the normative serum cortisol levels during 25–29 weeks of POG and the association of maternal, psychological, and social factors on serum cortisol in the second and third trimesters in a cohort of pregnant women.

Methods

All eligible pregnant women registered in the maternal care program in Anuradhapura district, Sri Lanka, from July to September 2019 were invited to the Rajarata Pregnancy Cohort (RaPCo). An interviewer-administered questionnaire-based symptom analysis and clinical assessment were conducted at baseline in the first trimester and at follow-up from 25 to 29 weeks POG. We assessed fasting early morning serum cortisol levels at the follow-up visit.

Results

The study sample included 1010 pregnant women with a mean age in years and POG in weeks at baseline of 28 (±6) and 10 (±3), respectively. The mean (SD, 97% percentile) serum cortisol level in all pregnant women was 10.93 (±3.83, 20.95) μg/dL, with no significant difference between singleton and twin pregnancies (p = 0.138). None of the study participants had a cortisol level exceeding the upper limit of 42 μg/dL, and 464 (45.9%) had levels less than 10 μg/dL. Serum cortisol levels were higher in women with an advanced POG, with a mean of 10.33 µg/dL (95%CI: 9.68–10.98) at 24 weeks POG and 12.23 µg/dL (95%CI: 11.15–13.32) at 29 weeks POG (p = 0.049). Primi-gravidity (p = 0.004), history of miscarriage (p = 0.010), BMI categories (p = 0.044), and POG (p = 0.002) were independently associated with serum cortisol levels in robust regression. An EPDS score of more than 9 was not associated with serum cortisol (p = 0.633).

Conclusion

The pregnant women in rural Sri Lanka reported a low mean serum cortisol level, which gradually increased with the POG. Significantly higher mean serum cortisol was associated with primi-gravidity, history of miscarriage, pre-pregnancy BMI, and POG at cortisol test, but not psychological factors.

Introduction

Maternal stress during pregnancy plays a critical role in maternal and fetal well-being. Stress during preconception and the antenatal period adversely affects maternal and fetal health through the dysregulation of the hypothalamic-pituitary axis [1]. Maternal stress increases the risk of maternal complications, including eclampsia, premature labor, and postpartum hemorrhage [24]. Recent evidence synthesis indicates that maternal stress is implicated in intrauterine growth restriction, prematurity, and low birth weight [5]. It is also associated with developmental disorders and childhood physical and psychological disorders [6,7]. Thus, maternal stress during pregnancy and its causes should be explored in depth to ensure safe motherhood and the well-being of their offspring.

Currently, maternal stress is measured in two broad approaches: cortisol level and psychometric tools [8]. Different measures of cortisol, such as serum, urinary, hair, and diurnal cortisol, are currently used to assess stress [9]. Cortisol, the stress hormone, is considered a better objective indicator of physiological stress compared to the subjective evaluations conducted using psychometric tools [1012]. Maternal cortisol, the final product of the hypothalamic-pituitary axis, is a key hormone in fetal development and maturation [13]. A recent study indicates that maternal serum total cortisol increased on average during pregnancy from 390 (±22) nmol/L in the 5th week to 589 (±15) nmol/L in the 20th week [14]. Current evidence suggests that high serum cortisol of more than 17.66 μg/dL (488 nmol/L) is significantly associated with developing postpartum depression [15]. However, studies from low socio-economic countries scarcely include measurement of cortisol levels in pregnancy [9].

The factors contributing to maternal stress are diverse, and perceived maternal stress is associated with circumstantial factors such as marital status, unplanned pregnancy, societal factors such as support from extended family, factors such as teenage pregnancy, domestic abuse, psychological factors, and economic factors [16]. Furthermore, emotional lability and physiological changes in pregnancy, such as weight gain, nausea, and insomnia, also contribute to significant stress during pregnancy [1719]. Elevated cortisol levels are known to be associated with maternal depression and adverse birth outcomes [20]. This is further compounded in complicated pregnancies [21].

Although Sri Lanka is a lower-middle-income country with comparatively high maternal health indicators, current evidence points to high levels of antenatal anxiety, depression, and maternal suicides [2224]. There are no studies reporting serum cortisol levels or predictors of cortisol in pregnant women of Sri Lanka. The current study investigates the normative data of serum cortisol levels in the second and third trimesters in a large population-based cohort and explores the association of maternal biological and psychosocial stressors with the serum cortisol level in the second trimester.

Methodology

Study design

We conducted a population-based prospective cohort study. The detailed methodology has been published [25].

Study setting

This study was conducted in Anuradhapura, geographically the largest district in Sri Lanka. It is predominantly rural with mostly Sinhalese (91%), followed by Sri Lankan Moors (8.2%), Tamils (0.6%), and other minority groups (0.2%) [26]. The female literacy rate is 91.7% and 37.1% of female adults participate in economic activities in Anuradhapura, Sri Lanka [27]. Each year, over 15,000 expectant mothers enroll in public antenatal care services in Sri Lanka. These services are delivered through divisional units within the Medical Officer of Health (MOH) areas. The district consists of 22 MOH areas, where all pregnant women are systematically registered by public health midwives (PHM), either during field visits or at their initial antenatal appointment.

Study population

The target population comprised pregnant women residing in the Anuradhapura district, North Central Province, Sri Lanka, who were eligible for enrolment based on the following criteria: (i) registration with the national maternal care program between 1 July and 30 September 2019, (ii) confirmed pregnancy with a period of amenorrhea less than 12 weeks at the time of registration, and (iii) permanent residence within the study district. The national maternal care program achieves over 95% population coverage, enabling near-complete enrolment of eligible pregnancies into antenatal care services [28].

Study sample

A total of 3,374 pregnant women were recruited for the original cohort study [29]. Of these, 1,450 participants attended the first follow-up visit, which occurred during the late second or early third trimester. Among those who attended the follow-up, 1,290 (89.0%) underwent serum cortisol testing. At this follow-up, gestational age was re-estimated based on first-trimester dating ultrasound scans. For the present analysis, a subset of 1,010 women with recalculated gestational ages between 25 and 29 weeks at the time of cortisol sampling was selected.

Procedure

At the baseline, all participants underwent a detailed clinical interview, anthropometric assessments, and venipuncture for blood and serum investigations in addition to routine maternal care. Interviewer-based questionnaires were completed by medically trained data collectors to gather participants’ sociodemographic, medical, psychological, and social information. Anthropometric measurements included weight, height, waist circumference, and hip circumference to assess body mass index (BMI) and waist-to-hip ratio according to standard protocols.

During the follow-up visit between 25 and 29 weeks of POG, fasting early morning serum cortisol levels were obtained by a trained phlebotomist after adequate resting for each participant, obtaining blood in a single prick. The analytical work was conducted by an accredited external laboratory using a fully automated analyzer based on the electrochemiluminescence immune assay method. The validated and culturally-adopted Edinburgh Postnatal Depression Scale (EPDS) was used to assess antenatal depression in the first (POG less than 13 weeks) and second visits (POG 25–29) [30,31]. Furthermore, attempts or ideation of deliberate self-harm and/or suicide, and intimate partner violence and/or abuse were assessed in the second trimester.

Statistical analysis

The distribution of cortisol levels from 25 to 29 weeks of POG was assessed for the whole study sample and singleton pregnancies. We considered a serum cortisol level of 10 μg/dL to 42 μg/dL as normal [32]. The serum cortisol level was described and compared based on the trimester, number of fetuses, gravidity, parity, maternal age, contraceptive failure, history of miscarriage, BMI category, waist-to-hip ratio, glycemic status, demographic factors, including maternal and paternal ethnicity, religion, and highest grade completed in school, and factors on mental health. The mean comparison of two groups and more than two groups was conducted with an independent sample T-test and one-way ANOVA, respectively, with a significance (p) of 0.05. One-way ANOVA was conducted to compare the mean serum cortisol levels of women with a POG between 24 and 29 weeks with Levene’s test to test the heterogeneity of variances, and, if heterogeneous, Games-Howell post hoc comparisons were used. The association between total EPDS score and components (anhedonia, anxiety, and depression) in the first trimester and the mean serum cortisol level was explored with an independent sample T-test or one-way ANOVA [33]. Variables found to be significant (p < 0.05) in the bivariate analysis were further evaluated using multivariable regression to identify independent associations with serum cortisol levels. In addition to these variables, marital status and maternal education were included in the model due to their potential confounding effects. Parity was excluded because of multicollinearity with gravidity. Given that serum cortisol was not normally distributed, the dependent variable was log-transformed to satisfy the assumptions of linear regression and improve model performance. After comparing model diagnostics, robust linear regression was selected over standard ordinary least-squares regression, as it provides more reliable estimates in the presence of outliers and non-constant variance in residuals.

Ethical considerations

Ethical approval for the study was obtained from the Ethics Review Committee of the FMAS, RUSL (ERC/2019/07). Informed written consent was obtained from the participant, and if the participant was less than 18 years of age, consent from parent(s) and/or guardian(s) and written assent from the participant were obtained before recruiting to the study.

Results

Characteristics of the study sample

The study sample included 1010 pregnant women between 15–45 years of age (Table 1). The mean (SD) age at conception was 27.6 (±5.7). There were 82 (8.1%) teenage pregnancies (age at conception less than 20 years), while most women belonged to the 25–29 age category (n = 351, 34.8%). In this study sample, 23 (2.3%) were not married. Most women were in their first (n = 317, 31.4%) or second pregnancy (n = 316, 31.3%). Contraceptive failure was the reason for pregnancy in 26 (2.6%) of pregnancies. A history of miscarriage was reported by 189 (18.7%) women. Most participants belonged to the normal body mass index (n = 361, 35.7%), and the waist-to-hip ratio of more than 0.85 (n = 349, 34.6%) categories.

Table 1. Biological factors affecting cortisol levels in the second and third trimesters of pregnant women from Anuradhapura, Sri Lanka (N = 1010).

Cortisol level (μg/dL)
N Percentage (%) Mean Standard deviation Median Significance
Age at conception (years) F(5,1010)=4.54
 Less than 20 82 8.1 12.45 4.73 11.15 p < 0.001
 20-24 209 20.7 11.16 3.63 10.46
 25-29 351 34.8 10.93 3.65 10.26
 30-34 236 23.4 10.72 4.15 9.98
 35-39 115 11.4 10.01 3.11 9.90
 More than 40 17 1.7 9.87 2.21 10.16
Pregnancy T = −1.48
 Singleton 1005 99.5 10.92 3.81 10.30 p = 0.138
 Twin 5 0.5 13.46 6.93 10.68
Period of gestation at cortisol test (weeks) F(5,1010)=3.71
 24 75 7.4 10.33 2.82 10.28 p = 0.002
 25 182 18.0 10.55 3.38 10.18
 26 248 24.6 10.68 3.45 10.21
 27 254 25.1 10.84 3.95 10.10
 28 156 15.4 11.41 3.84 10.34
 29 95 9.4 12.23 5.33 11.15
Body Mass Index F(3,974)=3.30
 Underweight 172 17.0 11.69 4.34 10.85 p = 0.020
 Normal 361 35.7 10.77 3.61 10.27
 Overweight 155 15.3 11.13 4.04 10.41
 Obese 286 28.3 10.60 3.65 9.96
Waist-to-hip ratio F(2,970)=1.64
 Less than 0.8 319 31.6 11.15 4.11 10.41 p = 0.195
 0.8 to 0.849 302 29.9 11.09 3.94 10.42
 More than 0.85 349 34.6 10.66 3.44 9.99
Glycemic status F(2,947)=1.47
 Gestational DMa 54 5.3 10.39 3.37 9.46 p = 0.229
 Preexisting DMa 17 1.7 9.74 1.97 9.86
 Normoglycemia 876 86.7 10.99 3.88 10.32
Gravidity F(3,1009)=5.51
 Primi 317 31.4 11.62 4.35 10.59 p < 0.001
 Second 316 31.3 10.80 3.25 10.47
 Third 251 24.9 10.45 3.60 9.84
 Four or more 125 12.4 10.48 4.01 10.09
Parity F(3,1009)=7.70
 Nulliparous 359 35.5 11.66 4.36 10.59 p < 0.001
 One 348 34.5 10.75 3.05 10.43
 Two 258 25.5 10.27 3.72 9.84
 Three or more 44 4.4 10.30 4.40 9.02
History of miscarriage T = −2.38
 Yes 189 18.7 11.13 4.20 10.38 p = 0.018
 No 502 49.7 10.42 3.22 10.06
Contraceptive failure T = −1.51
 Yes 26 2.6 12.05 5.66 10.61 p = 0.13
 No 984 97.4 10.90 3.78 10.27

aDM = diabetes mellitus.

Normative serum cortisol data in 24–29 weeks of POG

The distribution of cortisol levels in this study was skewed right (Shapiro-Wilk = 0.86, p < 0.01). The mean (SD, 97.5% percentile) serum cortisol level of the study sample was 10.93 (±3.83, 20.95) μg/dL, and there was no significant difference (p = 0.138) between the mean serum cortisol levels of singleton (10.92 ± 3.81 μg/dL) and twin pregnancies (13.46 ± 6.93 μg/dL) (Fig 1). None of the study participants had a cortisol level exceeding the upper limit of 42 μg/dL, and 464 (45.9%) had levels less than 10 μg/dL, with 236 (50.9%) in the second trimester and 228 (49.1%) in the third trimester. Serum cortisol levels gradually increased with the POG, with a mean of 10.33 µg/dL (95%CI: 9.68–10.98) at 24 weeks POG and 12.23 µg/dL (95%CI: 11.15–13.32) at 29 weeks POG (Fig 2). One-way ANOVA was conducted for those who are between 24 and 29 weeks, and it indicated a significant effect of POG on serum cortisol levels (F (5, 1010) =3.71, p = 0.002) but with a small effect size (η2 = 0.02). Levene’s test was significant (p = 0.002), indicating heterogeneity of variances, and, thus, Games-Howell post hoc comparisons were used. A significant difference was observed only between 24 weeks POG and 29 weeks POG (p = 0.049), with no other comparisons reaching statistical significance.

Fig 1. Distribution of cortisol in all pregnant women (left) and in singleton pregnancies (right).

Fig 1

Fig 2. Distribution of mean serum cortisol level (μg/dL) by the period of gestation (POG) in weeks.

Fig 2

Association of serum cortisol levels with biological and maternal factors

A significantly higher mean serum cortisol level was detected in primi-gravida (one-way ANOVA F (3, 1009) =5.51, p < 0.001), nulliparous women (one-way ANOVA F (3, 1009) =7.70, p < 0.001), teenage pregnancies (T = 3.78 p < 0.001) and women with a history of miscarriage (T = −2.38, p = 0.018) compared to their respective counterparts (Fig 3). There was a significant difference between the mean serum cortisol levels of underweight, normal weight, overweight, and obese individuals (one-way ANOVA F (3, 974) =3.30, p = 0.020). However, there was no significant difference in the mean serum cortisol levels between the groups based on the waist-to-hip ratio (one-way ANOVA F (2, 970) =1.64, p = 0.195) or the glycemic status (gestational diabetes mellitus, pre-existing diabetes mellitus, and normoglycemia) (one-way ANOVA F (2, 947) =1.47, p = 0.229). Maternal ethnicity (one-way ANOVA F (2, 1000) =0.414, p = 0.661), religion (one-way ANOVA F (2, 1010) =0.827, p = 0.438), highest grade completed in school (one-way ANOVA F (2, 1003) =0.073, p = 0.930) or paternal ethnicity (one-way ANOVA F (2, 1007) =0.300, p = 0.741), religion (one-way ANOVA F (2, 1008) =0.614, p = 0.541), highest grade completed in school (one-way ANOVA F (2, 998) =1.057, p = 0.350) were associated with a higher mean serum cortisol level.

Fig 3. Distribution of serum cortisol level by the age at conception in years (top), parity (middle), and gestational age in completed weeks (bottom).

Fig 3

Association of serum cortisol levels with sociodemographic and psychological factors

An EPDS score of more than 9 was not associated with serum cortisol (p = 0.633). The first-trimester EPDS scores of anhedonia (one-way ANOVA F(641,963)=1.01, p = 0.444), anxiety (one-way ANOVA F(641,963)=0.96, p = 0.655), or depression (due to low numbers with each score, participants with a score of 10 or more were amalgamated into one group) (one-way ANOVA F(641,963)=1.13, p = 0.103) in the first trimester did not predict mean serum cortisol in the second and third trimester (Table 2). Similarly, suicidal attempts (p = 0.185), suicidal ideation (p = 0.572), and attempts at deliberate self-harm (p = 0.631) were not associated with serum cortisol levels. The serum cortisol level was not associated with the EPDS score in the second trimester (one-way ANOVA F (599, 872) =0.96, p = 0.663).

Table 2. Sociodemographic factors and psychological factors affecting cortisol levels in the second and third trimesters in pregnant women from Anuradhapura, Sri Lanka (N = 1010).

Cortisol level (μg/dL)
N Percentage (%) Mean Standard deviation Median Significance
Demographic factors
Marital status (at recruitment) T = −1.01
 Married 987 97.7 10.91 3.81 10.29 p = 0.269
 Unmarried 23 2.3 11.80 4.37 10.63
Maternal ethnicity F(2,1000)=0.41
 Sinhalese 916 90.7 10.90 3.85 10.27 p = 0.661
 Moor/ Malay 84 8.3 11.24 3.71 10.53
 Other 10 1.0 11.48 2.35 11.53
Maternal religion F(2,1010)=0.83
 Buddhism 908 89.9 10.91 3.86 10.29 p = 0.438
 Islam 89 8.9 11.26 3.66 10.18
 Other 13 1.3 9.89 1.61 9.45
Highest grade completed in school (maternal) F(2,1003)=0.07
 Grade 10 or less 85 8.4 11.06 3.35 10.39 p = 0.930
 Grade 11 515 51.0 10.96 3.81 10.34
 Grade 12–13 403 39.9 10.90 3.96 10.18
Paternal ethnicity F(2,1007)=0.30
 Sinhalese 913 90.4 10.90 3.86 10.26 p = 0.741
 Moor/ Malay 79 7.8 11.20 3.76 10.40
 Other 15 1.5 11.34 2.42 11.52
Paternal religion F(2,1008)=0.61
 Buddhism 905 89.6 10.91 3.86 10.27 p = 0.541
 Islam 90 8.9 11.26 3.63 10.62
 Other 13 1.3 10.15 2.83 10.53
Highest grade completed in school (paternal) F(2,998)=1.05
 Grade 10 or less 128 12.7 10.52 3.35 9.98 p = 0.350
 Grade 11 567 56.1 11.06 4.08 10.31
 Grade 12–13 301 30.0 10.92 3.55 10.47
Psychological health
Edinburgh postpartum depression scale score quintile (first visit) F(4,986)=1.245
 First 219 22.20 11.02 3.44 10.53 p = 0.290
 Second 179 18.20 11.46 3.98 10.71
 Third 325 33.00 10.73 3.98 10.19
 Fourth 82 8.30 10.95 4.15 10.08
 Fifth 181 18.40 10.73 3.61 10.27
Self-harm ideation during the past two weeks (first visit) T = −0.12
 Yes often 17 1.80 10.80 3.02 10.52 p = 0.903
 No/ occasionally 946 98.20 10.91 3.76 10.32
Edinburgh postpartum depression scale score quintile (second visit) F(3,672)=0.23
 First 200 22.90 10.43 3.39 9.78 p = 0.631
 Second 180 20.60 11.06 4.04 10.25
 Third 205 23.50 11.08 3.82 10.43
 Fourth 143 16.40 11.39 3.62 10.59
 Fifth 144 16.50 10.8 4.42 10.34
Self-harm ideation during the past two weeks (second visit) T = 0.91
 Yes often 34 3.90 11.47 4.58 10.56 p = 0.367
 No/ occasionally 849 96.10 10.88 3.7 10.25
Deliberate self-harm attempts during the current pregnancy
 Yes 13 1.40 11.44 5.23 10.10 T = 0.481
 No 937 98.60 10.92 3.85 10.29 p = 0.631
Suicidal ideation during current pregnancy T = 0.57
 Yes 11 1.20 11.58 5.31 10.10 p = 0.572
 No 938 98.80 10.92 3.85 10.29
Suicide attempts during current pregnancy T = 1.33
 Yes 8 0.80 9.12 1.41 8.99 p = 0.185
 No 940 99.20 10.94 3.88 10.3
Lifetime perception of life as not worth living T = 1.06
 Yes often 4 0.40 12.98 1.58 13.02 p = 0.287
 No/ occasionally 946 99.60 10.92 3.87 10.27
History of mental or physical abuse by an intimate partner T = 1.30
 Yes 19 2.20% 12.07 5.9 9.88 p = 0.194
 No 850 97.80% 10.91 3.8 10.3
Perceived susceptibility to mental health issues T = 1.41
 Yes 19 2.30% 12.21 3.6 11.18 p = 0.157
 No 819 97.70% 10.94 3.89 10.28

Independent predictors of serum cortisol level

The robust regression analysis showed that a history of miscarriages (ß = 0.081, 95%CI 0.020 to 0.142, p = 0.010) and POG at cortisol test (ß = 0.015, 95%CI 0.006 to 0.025, p = 0.002) were positively associated with serum cortisol levels, whereas BMI (ß = −0.004, 95%CI −0.009 to −0.001, p = 0.044) and gravidity (ß = −0.044, 95%CI −0.074 to −0.014, p = 0.004) were negatively associated (Table 3). These associations remained significant after adjusting for potential confounders.

Table 3. Robust Regression to determine independent predictors of serum cortisol level.

Variable df Coefficient 95%CI Significance
(p-value)
lower upper
Constant 822 2.164 1.787 2.540 <0.001
Age 822 −0.002 −0.006 0.003 0.505
Education level 822 −0.004 −0.018 0.009 0.524
Marital status 822 0.036 −0.101 0.173 0.605
Gravidity 822 −0.044 −0.074 −0.014 0.004
History of miscarriages 822 0.081 0.020 0.142 0.010
Body-mass-index 822 −0.004 −0.009 −0.001 0.044
Period of gestation at cortisol test 822 0.015 0.006 0.025 0.002

Pregnancy outcomes

Pregnancy outcomes were available for 990 participants (98.0%), including 985 live births (99.5%), 3 stillbirths (0.3%), and 2 intrauterine deaths ≥28 weeks of gestation (0.2%). Among live births, 4 early neonatal deaths (<7 days) and 5 infant deaths (<12 months) were reported. Preterm birth occurred in 208 cases (21.1%), including 10 very preterm (1.0%) and 3 extreme preterm deliveries (0.3%). Mean serum cortisol levels did not differ significantly between preterm (11.14 ± 3.74 µg/dL) and term births (10.87 ± 3.87 µg/dL; p = 0.372). Of 968 births with available weight data, 153 (15.8%) were low birth weight, 4 (0.4%) were very low birth weight, and none were extremely low birth weight. Cortisol levels were comparable between low birth weight (10.87 ± 3.53 µg/dL) and normal birth weight deliveries (10.94 ± 3.91 µg/dL; p = 0.837).

Discussion

We report normative data for serum cortisol levels in pregnancy and examine the factors associated with maternal serum cortisol in a large population-based cohort from rural Sri Lanka for the first time in Sri Lanka. The mean serum cortisol level in the study sample was close to the lower limit, with none of the study participants exceeding the upper limit of the standard levels [32]. There was no significant difference between singleton and twin pregnancies. Serum cortisol levels in participants with 29-week POG were higher than in women with 24-week POG. The robust regression analysis showed that a history of miscarriages and POG at the cortisol test were positively associated with serum cortisol levels, whereas BMI and gravidity were negatively associated. We did not observe an association of serum cortisol with psychosocial factors.

Normative levels

The current study includes all pregnant women enrolled in the maternal care program from the Anuradhapura district, Sri Lanka, validating the normative data presented. In this study, the mean serum cortisol level was low, and the upper limit of cortisol level was not exceeded in any participant. However, this result should be interpreted with caution as chronic stress may not result in elevated serum cortisol levels [34]. The mean cortisol levels reported from Southern Brazil in the first, second, and third trimesters were 28.5 μg/dl (95%CI: 26.1 to 31.2), 42.6 μg/dl (95%CI: 41.0 to 44.2), and 54.4 μg/dl (95%CI: 51.4 to 57.7), respectively with an increase of 2.0% (95%CI 1.01 to 1.02, p < 0.001) each week [35]. Normal levels reported in Melbourne, Australia, in the first, second, and third trimesters were 20.92 ± 1.09 μg/dL, 31.84 ± 1.01 μg/dL, and 37.81 ± 1.49 μg/dL, respectively. However, further prospective cohort studies should be conducted in different geographies and populations to corroborate these findings. The non-significant difference between singleton and twin pregnancies in the current study is probably attributable to the low number of twin pregnancies, which resulted in a large standard deviation despite the apparent difference in the mean. The increase in cortisol levels with POG follows the known pattern of increasing from the first to the third trimester and during labor [12,14,36].

Maternal factors

We report significantly higher serum cortisol levels in primi, nulliparous, and teenage pregnant women and women with past miscarriages compared to their counterparts. Robust regression was used to account for the presence of outliers and deviations from the assumptions of standard linear regression. This approach enhanced the reliability of our findings, especially given the skewed nature of cortisol data and biological variability among participants. It showed similar results: a positive association between POG and a history of miscarriage, and an inverse relationship with BMI and gravidity. The negative association of gravidity with serum cortisol levels may reflect physiological or psychological adaptation in women with previous pregnancies [37]. It is possible that women who have experienced multiple pregnancies develop better coping mechanisms or reduced hypothalamic-pituitary-adrenal (HPA) axis reactivity over time. In contrast, the positive association between a history of miscarriages and cortisol levels even in the second and third trimesters may indicate increased stress or anxiety in subsequent pregnancies, which has not been adequately explored. The negative association of gravidity with serum cortisol levels may reflect physiological or psychological adaptation in women with previous pregnancies [37]. It is possible that women who have experienced multiple pregnancies develop better coping mechanisms or reduced hypothalamic-pituitary-adrenal (HPA) axis reactivity over time. In contrast, the positive association between a history of miscarriages and cortisol levels even in the second and third trimesters may indicate increased stress or anxiety in subsequent pregnancies, which has not been adequately explored. Similar to the current study, there was a significant difference between the mean serum cortisol levels of underweight, normal-weight, overweight, and obese individuals in other studies [38]. Several studies have shown that women with pre-pregnancy obesity have a lower level of salivary [39] and serum cortisol compared to lean women without an increase in urinary glucocorticoid clearance, suggestive of decreased maternal hypothalamic-pituitary axis activity [40].

Known stressors in early pregnancy, such as marital status and contraceptive failure, were not significantly associated with serum cortisol levels in this study. However, contrary results similar to the current study were reported from a prospective cohort study from Bangalore, where a significant difference in cortisol levels was found for maternal age and gravidity, but no other pregnancy-related stressors such as history of abortion, social support, and spousal alcohol consumption or smoking [15].

Serum cortisol and psychosocial factors

Current study results did not show an association between the serum cortisol level in 24–29 weeks of POG with the EPDS score or other psychosocial factors. However, this may be attributable to the extensive supportive program, which included targeted interventions such as counseling, health education, financial and social support, and psychiatric referral as appropriate, conducted for the participants with high EPDS or psychological risk factors in the first-trimester screening [23]. Previous studies have shown mixed results on the association between subjective measures of depression or stress and serum cortisol levels [41,42]. However, current evidence favors maternal cortisol levels over subjective measures as a predictor of offspring outcomes [11]. Therefore, it is recommended to assess maternal cortisol in future studies and explore the public health implications of high maternal serum cortisol.

Strengths and limitations

This is a prospective cohort study with a large sample size with only 3 other studies having a larger sample size, which were mainly from the developed countries. Furthermore, this is a population-based cohort study including all pregnant women residing in the Anuradhapura district, North Central Province, Sri Lanka, and registered with the national maternal care program from 1st July to 30th September 2019 and with a POG of less than 13 weeks. The national maternal care program has 95% antenatal coverage. Therefore, this study sample includes a representative population. A structured questionnaire administered by trained medical care personnel was used to evaluate psychological stressors. Furthermore, physical measurements were conducted by trained medical personnel. The fasting early-morning serum cortisol levels were evaluated in all participants after an adequate test by a trained phlebotomist and evaluated on the same day at an accredited laboratory. The current study did not evaluate hair or salivary cortisol levels for corroboration with serum cortisol levels due to budgetary concerns and the lack of accredited laboratory facilities.

Conclusion

The mean serum cortisol level in all pregnant women was 10.93(±3.83) μg/dL, with none of the participants exceeding the upper limit and with no significant difference between singleton and twin pregnancies. Serum cortisol levels gradually increased with the POG, with a significant difference observed between POG 24 and POG 29 weeks. A history of miscarriages and POG at cortisol test were positively associated with serum cortisol levels, whereas BMI was negatively associated. A high EPDS score or other psychological stressors were not associated with the serum cortisol level.

Acknowledgments

The author Shashanka Rajapakse expresses their appreciation for the support from the International Cooperation & Education Program (NCCRI·NCCI 52210–52211, 2024) of the National Cancer Center, Korea.

Data Availability

All deidentified data of the participants included in the current study of the Rajarata Pregnancy Cohort (RaPCO) is deposited under the doi: https://doi.org/10.5281/zenodo.15074568 at the https://zenodo.org/records/15074568.

Funding Statement

The original cohort study was supported by the Accelerating Higher Education Expansion and Development (AHEAD) Operation of the Ministry of Higher Education, Sri Lanka funded by the World Bank [grant number DOR STEM HEMS [6026-LK/8743-LK]]. The funding agency has no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

References

  • 1.Cottrell EC, Seckl JR. Prenatal stress, glucocorticoids and the programming of adult disease. Front Behav Neurosci. 2009;3:19. doi: 10.3389/neuro.08.019.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.González-Ochoa R, Sánchez-Rodríguez EN, Chavarría A, Gutiérrez-Ospina G, Romo-González T. Evaluating Stress during Pregnancy: Do We Have the Right Conceptions and the Correct Tools to Assess It? J Preg. 2018;2018:4857065. doi: 10.1155/2018/4857065 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Austin MP, Leader L. Maternal stress and obstetric and infant outcomes: epidemiological findings and neuroendocrine mechanisms. Aust N Z J Obstet Gynaecol. 2000;40(3):331–7. doi: 10.1111/j.1479-828x.2000.tb03344.x [DOI] [PubMed] [Google Scholar]
  • 4.Vianna P, Bauer ME, Dornfeld D, Chies JAB. Distress conditions during pregnancy may lead to pre-eclampsia by increasing cortisol levels and altering lymphocyte sensitivity to glucocorticoids. Med Hypotheses. 2011;77(2):188–91. doi: 10.1016/j.mehy.2011.04.007 [DOI] [PubMed] [Google Scholar]
  • 5.Ding X, Liang M, Wu Y, Zhao T, Qu G, Zhang J, et al. The impact of prenatal stressful life events on adverse birth outcomes: A systematic review and meta-analysis. J Affect Disord. 2021;287:406–16. doi: 10.1016/j.jad.2021.03.083 [DOI] [PubMed] [Google Scholar]
  • 6.Caparros-Gonzalez RA, Torre-Luque A de la, Romero-Gonzalez B, Quesada-Soto JM, Alderdice F, Peralta-Ramírez MI. Stress During Pregnancy and the Development of Diseases in the offspring: A Systematic-Review and Meta-Analysis. Midwifery. 2021;97:102939. doi: 10.1016/j.midw.2021.102939 [DOI] [PubMed] [Google Scholar]
  • 7.Janssen LE, Gieskes AA, Kok M, de Groot CJM, Oudijk MA, de Boer MA. Stress-reducing interventions in pregnancy for the prevention of preterm birth: a systematic review and meta-analysis. J Psychosom Obstet Gynaecol. 2023;44(1):2281238. doi: 10.1080/0167482X.2023.2281238 [DOI] [PubMed] [Google Scholar]
  • 8.Patel I, Dev A. What is prenatal stress? A scoping review of how prenatal stress is defined and measured within the context of food insecurity, housing instability, and immigration in the United States. Womens Health (Lond). 2023;19:17455057231191091. doi: 10.1177/17455057231191091 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rinne GR, Hartstein J, Guardino CM, Dunkel Schetter C. Stress before conception and during pregnancy and maternal cortisol during pregnancy: A scoping review. Psychoneuroendocrinology. 2023;153:106115. doi: 10.1016/j.psyneuen.2023.106115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Bolten MI, Wurmser H, Buske-Kirschbaum A, Papoušek M, Pirke K-M, Hellhammer D. Cortisol levels in pregnancy as a psychobiological predictor for birth weight. Arch Womens Ment Health. 2011;14(1):33–41. doi: 10.1007/s00737-010-0183-1 [DOI] [PubMed] [Google Scholar]
  • 11.Caparros-Gonzalez RA, Lynn F, Alderdice F, Peralta-Ramirez MI. Cortisol levels versus self-report stress measures during pregnancy as predictors of adverse infant outcomes: a systematic review. Stress. 2022;25(1):189–212. doi: 10.1080/10253890.2022.2059348 [DOI] [PubMed] [Google Scholar]
  • 12.Rinne GR, Hartstein J, Guardino CM, Dunkel Schetter C. Stress before conception and during pregnancy and maternal cortisol during pregnancy: A scoping review. Psychoneuroendocrinology. 2023;153:106115. doi: 10.1016/j.psyneuen.2023.106115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Benediktsson R, Calder AA, Edwards CR, Seckl JR. Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol (Oxf). 1997;46(2):161–6. doi: 10.1046/j.1365-2265.1997.1230939.x [DOI] [PubMed] [Google Scholar]
  • 14.Vrijkotte T, de Rooij SR, Roseboom TJ, Twickler T. Maternal serum cortisol levels during pregnancy differ by fetal sex. Psychoneuroendocrinology. 2023;149:105999. doi: 10.1016/j.psyneuen.2022.105999 [DOI] [PubMed] [Google Scholar]
  • 15.Shriyan P, Sudhir P, van Schayck OCP, Babu GR. Association of high cortisol levels in pregnancy and altered fetal growth. Results from the MAASTHI, a prospective cohort study, Bengaluru. Lancet Reg Health Southeast Asia. 2023;14:100196. doi: 10.1016/j.lansea.2023.100196 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kashanian M, Faghankhani M, YousefzadehRoshan M, EhsaniPour M, Sheikhansari N. Woman’s perceived stress during pregnancy; stressors and pregnancy adverse outcomes. J Matern Fetal Neonatal Med. 2021;34(2):207–15. doi: 10.1080/14767058.2019.1602600 [DOI] [PubMed] [Google Scholar]
  • 17.Parcells DA. Women’s mental health nursing: depression, anxiety and stress during pregnancy. J Psychiatr Ment Health Nurs. 2010;17(9):813–20. doi: 10.1111/j.1365-2850.2010.01588.x [DOI] [PubMed] [Google Scholar]
  • 18.Kominiarek MA, Grobman W, Adam E, Buss C, Culhane J, Entringer S, et al. Stress during pregnancy and gestational weight gain. J Perinatol. 2018;38(5):462–7. doi: 10.1038/s41372-018-0051-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Coussons-Read ME. Effects of prenatal stress on pregnancy and human development: mechanisms and pathways. Obstet Med. 2013;6(2):52–7. doi: 10.1177/1753495X12473751 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Castro-Quintas Á, Eixarch E, Martin-Gonzalez NS, Daura-Corral M, Marques-Feixa L, Palma-Gudiel H, et al. Diurnal cortisol throughout pregnancy and its association with maternal depressive symptoms and birth outcomes. Psychoneuroendocrinology. 2024;161:106930. doi: 10.1016/j.psyneuen.2023.106930 [DOI] [PubMed] [Google Scholar]
  • 21.Wu Y, Andescavage N, Lopez C, Quistorff JL, Donofrio MT, du Plessis AJ, et al. Maternal mental distress and cortisol levels in pregnancies with congenital heart disease. Cardiol Young. 2022;32(6):975–9. doi: 10.1017/S1047951121003504 [DOI] [PubMed] [Google Scholar]
  • 22.Agampodi SB, Agampodi TC. Antenatal Depression in Anuradhapura, Sri Lanka and the Factor Structure of the Sinhalese Version of Edinburgh Post Partum Depression Scale among Pregnant Women. PLoS ONE. 2013;8(7):e69708. doi: 10.1371/journal.pone.0069708 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Agampodi T, Amarasinghe G, Wickramasinghe A, Wickramasinghe N, Warnasekara J, Jayasinghe I, et al. Incorporating early pregnancy mental health screening and management into routine maternal care: experience from the Rajarata Pregnancy Cohort (RaPCo), Sri Lanka. BMJ Glob Health. 2023;8(9):e012852. doi: 10.1136/bmjgh-2023-012852 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Agampodi S, Wickramage K, Agampodi T, Thennakoon U, Jayathilaka N, Karunarathna D, et al. Maternal mortality revisited: the application of the new ICD-MM classification system in reference to maternal deaths in Sri Lanka. Reprod Health. 2014;11(1):17. doi: 10.1186/1742-4755-11-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Agampodi TC, Wickramasinghe ND, Prasanna RIR, Irangani MKL, Banda JMS, Jayathilake PMB, et al. The Rajarata Pregnancy Cohort (RaPCo): study protocol. BMC Pregnancy Childbirth. 2020;20(1):374. doi: 10.1186/s12884-020-03056-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Department of Census and Statistics C of population and housing. Population by Ethnicity and District According to Divisional Secretary’s Division. 2012 [cited 20 Mar 2025]. Available from: https://www.statistics.gov.lk/abstract2023/chapter2#gsc.tab=0
  • 27.Ministry of Finance ES and NP. Department of Census and Statistics. Sri Lanka Labour Force Survey Annual Report. 2022.
  • 28.Paradox of healthcare in Sri Lanka: A snapshot of the decade from a partnership of sixty years. [cited 17 Mar 2025]. Available from: https://iris.who.int/handle/10665/255195
  • 29.Agampodi SB, Wickramasinghe ND, Agampodi TC. Cohort Profile: The Rajarata Pregnancy Cohort (RaPCo). Anuradhapura Med J. 2023;17(1):31. doi: 10.4038/amj.v17i1.7757 [DOI] [Google Scholar]
  • 30.Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150:782–6. doi: 10.1192/bjp.150.6.782 [DOI] [PubMed] [Google Scholar]
  • 31.Kozinszky Z, Dudas RB. Validation studies of the Edinburgh Postnatal Depression Scale for the antenatal period. J Affect Disord. 2015;176:95–105. doi: 10.1016/j.jad.2015.01.044 [DOI] [PubMed] [Google Scholar]
  • 32.Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114(6):1326–31. doi: 10.1097/AOG.0b013e3181c2bde8 [DOI] [PubMed] [Google Scholar]
  • 33.Petrozzi A, Gagliardi L. Anxious and depressive components of Edinburgh Postnatal Depression Scale in maternal postpartum psychological problems. J Perinat Med. 2013;41(4):343–8. doi: 10.1515/jpm-2012-0258 [DOI] [PubMed] [Google Scholar]
  • 34.Seng JS, Low LK, Ben-Ami D, Liberzon I. Cortisol level and perinatal outcome in pregnant women with posttraumatic stress disorder: a pilot study. J Midwifery Womens Health. 2005;50(5):392–8. doi: 10.1016/j.jmwh.2005.04.024 [DOI] [PubMed] [Google Scholar]
  • 35.Xavier J, Borges Rubin B, Coelho Scholl C, Camerini L, Puchalski Trettim J, de Matos MB, et al. The hormonal trajectory along gestational age: Cortisol and oxytocin levels profiles. Psychoneuroendocrinology. 2025;171:107230. doi: 10.1016/j.psyneuen.2024.107230 [DOI] [PubMed] [Google Scholar]
  • 36.Chai Y, Wang H, Tang D, Wu Y, Sun Z, Zeng Y, et al. Changes of serum cortisol during pregnancy and labor initiation: an onsite cross-sectional study. Front Endocrinol (Lausanne). 2024;15:1379693. doi: 10.3389/fendo.2024.1379693 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Gillespie SL, Mitchell AM, Kowalsky JM, Christian LM. Maternal parity and perinatal cortisol adaptation: The role of pregnancy-specific distress and implications for postpartum mood. Psychoneuroendocrinology. 2018;97:86–93. doi: 10.1016/j.psyneuen.2018.07.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bleker LS, Roseboom TJ, Vrijkotte TG, Reynolds RM, de Rooij SR. Determinants of cortisol during pregnancy - The ABCD cohort. Psychoneuroendocrinology. 2017;83:172–81. doi: 10.1016/j.psyneuen.2017.05.026 [DOI] [PubMed] [Google Scholar]
  • 39.Aubuchon-Endsley NL, Bublitz MH, Stroud LR. Pre-pregnancy obesity and maternal circadian cortisol regulation: Moderation by gestational weight gain. Biol Psychol. 2014;102:38–43. doi: 10.1016/j.biopsycho.2014.07.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Stirrat LI, O’Reilly JR, Barr SM, Andrew R, Riley SC, Howie AF, et al. Decreased maternal hypothalamic-pituitary-adrenal axis activity in very severely obese pregnancy: Associations with birthweight and gestation at delivery. Psychoneuroendocrinology. 2016;63:135–43. doi: 10.1016/j.psyneuen.2015.09.019 [DOI] [PubMed] [Google Scholar]
  • 41.Lundholm C, Rejnö G, Brew B, Smew AI, Saltvedt S, Almqvist C. Associations Between Maternal Distress, Cortisol Levels, and Perinatal Outcomes. Psychosom Med. 2022;84(3):288–96. doi: 10.1097/PSY.0000000000001049 [DOI] [PubMed] [Google Scholar]
  • 42.Orta OR, Gelaye B, Bain PA, Williams MA. The association between maternal cortisol and depression during pregnancy, a systematic review. Arch Womens Ment Health. 2018;21(1):43–53. doi: 10.1007/s00737-017-0777-y [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Surangi Jayakody

24 Jun 2025

Dear Dr. Agampodi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:

The authors are to be commended for the successful submission of this manuscript, which addresses an important area of research with potential implications for maternal and fetal health. The use of a population-based prospective cohort design is a notable strength.<o:p></o:p>

However, there is some ambiguity regarding the timing of participant recruitment. While it is stated under the "Procedure" section (line 153) that recruitment occurred during the first trimester, it is also mentioned (lines 146–147) that serum cortisol levels were available only for 1,290 participants who attended follow-up visits in the second or third trimester. Although the authors refer to a previously published methodology, it would greatly improve the clarity of the current manuscript to explicitly state when participants included in this analysis were initially recruited. Clear delineation of the recruitment timeline would aid in understanding the study design and cohort selection.<o:p></o:p>

Please submit your revised manuscript by Aug 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Surangi Jayakody, MBBS, MSc, MD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf .

2. Thank you for stating in your Funding Statement:

“The original cohort study was supported by the Accelerating Higher Education Expansion and Development (AHEAD) Operation of the Ministry of Higher Education, Sri Lanka funded by the World Bank [grant number DOR STEM HEMS [6026-LK/8743-LK]]. The funding agency has no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.”

Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement.

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: I read the presented manuscript with great interest. I wish to commend the authors in presenting a large data set from a LMIC set up which is a difficult task to accomplish. The study presents descriptive data of maternal serum cortisol levels in a large cohort of pregnant women in the second trimester.

I have only a few comments to make.

1. Please highlight the fact that ALL women in the cohort had their cortisol levels with-in the accepted reference range for the gestation.

2. I agree with the authors that the relationship with EPDS score and maternal serum cortisol levels may not have shown a correlation due to the chronology of the measurements. Please make a clear statement of when the EPDS score was obtained and when the serum cortisol level was measured- what was the time difference between the two measurements.

3. If the authors can present pregnancy outcome data, please check for fetal outcomes in relationship with second trimester cortisol levels - eg, previous authors have presented a relationship with high normal (>17) second trimester cortisol levels with adverse fetal outcomes. (The data will be an useful addition for a systematic review/ meta analysis)

Reviewer #2: Thank you for conducting this research and comprehensive article . This gives eye open for pregnancy and its related factors in developing country. I thought increase in cortisol levels in psychological stresses but it was not. Very interesting article . Best wishes for future endeavours

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: Yes:  Dr. Chamara Wijemunige- Speciality Registrar in Obs & Gyne

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

PLoS One. 2025 Sep 8;20(9):e0322685. doi: 10.1371/journal.pone.0322685.r002

Author response to Decision Letter 1


22 Jul 2025

Response letter

The authors are highly appreciative and grateful for the excellent review process. We are delighted with the constructive, encouraging, and insightful comments of the editor and the reviewers. We strongly believe that the comments of the editor and the reviewers greatly enhanced the quality and the scientific impact of our manuscript. Furthermore, we are thankful for the comments to improve the comprehensibility and the understandability of our manuscript. We addressed all the comments and enhanced our manuscript as suggested.

Please see the detailed responce to all comments in the attched responce letter.

Attachment

Submitted filename: Response letter.docx

pone.0322685.s002.docx (20.5KB, docx)

Decision Letter 1

Surangi Jayakody

6 Aug 2025

Normative serum cortisol levels in second and third trimesters and their associated factors: A prospective cohort study from Sri Lanka

PONE-D-25-16021R1

Dear Dr. Agampodi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Surangi Jayakody, MBBS, MSc, MD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Surangi Jayakody

PONE-D-25-16021R1

PLOS ONE

Dear Dr. Agampodi,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr Surangi Jayakody

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response letter.docx

    pone.0322685.s002.docx (20.5KB, docx)

    Data Availability Statement

    All deidentified data of the participants included in the current study of the Rajarata Pregnancy Cohort (RaPCO) is deposited under the doi: https://doi.org/10.5281/zenodo.15074568 at the https://zenodo.org/records/15074568.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES